SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-187708
Filing Date
2014-05-07
Accepted
2014-05-07 17:10:33
Documents
3
Period of Report
2014-05-06
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d721856d8k.htm 8-K 15226
2 EX-3.1 d721856dex31.htm EX-3.1 24093
3 EX-3.2 d721856dex32.htm EX-3.2 98957
  Complete submission text file 0001193125-14-187708.txt   139615
Mailing Address 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803
Business Address 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803 617-513-9882
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36332 | Film No.: 14821940
SIC: 2834 Pharmaceutical Preparations